Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum. . Melanoma Res 2024;34:473.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum. Melanoma Res 2024;34:473.
PMID: 39206844